Download Programme

Programme
Wednesday 03rd April 2013
08.00–09.15
Registration
09.15-10.00
Welcome
Prof. Nicolae Victor Zamfir, General Director IFIN-HH
Dr. Ioan Ursu, Scientific Secretary IFIN-HH
10.00-10.30
CCR - Radiopharmaceuticals Research Centre
Dana Niculae, Department of Radioisotopes and Radiation Metrology, IFIN-HH
10.30-11.00
The new TR19 Cyclotron for PET radioisotopes production and Applied
Research in IFIN-HH
Liviu Craciun, Department of Applied Nuclear Physics, IFIN-HH
11.00-11.20
Cofee break
Radiopharmacy – a multidisciplinary approach
Chairmen Dana Niculae and Stefano Boschi
11.20-12.20
Invited lecture - The Role of PET in Molecular Oncology
Prof. John Mercer Oncologic Imaging, Faculty of Medicine and Dentistry,
University of Alberta / Cross Cancer Institute, Edmonton
12.20-13.00
Invited lecture – Radiopharmaceutical legislation in Europe
Prof. Clemens Decristoforo, Department of Nuclear Medicine, Medical University,
Innsbruck
13.00-13.20
The Role of the PET/CT Investigation in the Radiotherapy of Malignant Tumors
Prof. Christian Chiricuta, Amethyst Radiotherapy Center, Bucharest-Otopeni
13.20-13.40
Compared Oncology as Discipline of Medical Sciences
Prof. Nicolae Manolescu, Institute for Compared Oncology, Translational
Medicine, University of Veterinary Medicine, Bucharest
13.40-14.30
14.30-15.00
Lunch break
Visits at Radiopharmaceutical Research Centre and Radioisotopes Production
Centre
Planning and running a medical radioisotopes production facility
Chairmen Ioan Ursu and Liviu Craciun
15.00-15.30
The Debrecen Experience in PET Radiochemistry
Dr. Pal Mickecz, Department of Nuclear Medicine, MHSC, University of Debrecen
15.30-16.30
Metrological traceability assurance in production and use of radiopharmaceuticals
for PET imaging and targeted radiotherapy
Dr. Maria Sahagia, Department of Radioisotopes and Radiation Metrology, IFINHH
16.30-17.00
Establishing a PET Production Facility; Seven Alternative PET
Radiopharmaceutical Production Centers
Ayfer Asiye Soylu, Eczacıbaşı-Monrol Nuclear Products Company, Turkey
17.00-17.30
Radiation protection at radiopharmaceutical production sites
Dr. Radu A. Vasilache, Canberra Packard GmbH
Thuesday 04th April 2013
PET radioisotopes - clinical radiopharmacy
Chairmen Doina Draganescu and Clemens Decristoforo
09.15-10.00
Invited lecture – Fluorine-18 Radiopharmaceuticals for cancer imaging - 18F-FDG
and beyond.
Prof. John Mercer Oncologic Imaging, Faculty of Medicine and Dentistry,
University of Alberta / Cross Cancer Institute, Edmonton, Canada
10.00-10.45
Invited lecture - 11C Radiopharmaceuticals in clinical radiopharmacy: a ten years'
experience
Prof. Stefano Boschi, PET radiopharmacy, Department of Nuclear Medicine,
University Hospital, Bologna, Italy
10.45-11.05
Review of FDG PET-CT Application in Oncology
Mirela Gherghe, Euromedic Romania, Department of PET-CT
11.05-11.20
Cofee break
PET radioisotopes - chemistry
Chairmen Adriana Rimbu and Pal Mickecz
11.20-11.50
Development and application of chiral nickel complexes for the preparation of
carbon-11 and fluorine-18 labelled amino acids
Prof. Alexander Popkov, Department of Cognitive Research and Tomographic
Imaging Methods, Samo University, Pardubice, Czech Republic
11.50-12.20
Non-HPLC methods for the production of F-18, C-11 and Ga-68 PET tracers
Dr. Alexander Yordanov, Ezcacibasi-Monrol Nuclear Products, Turkey (Monrol
Bulgaria)
12.20-12.50
Development of high power Ni target for production of Cu 64 by a biomedical
cyclotron
Dr. Lidia Matei, Best Theratronics, Radiochemistry Division, Ottawa Canada;
12.50-13.10
Sponsor presentation - PET/CT in monitoring the patient response to oncological
treatment
Daniela Stanoi, GE Healthcare, GE Medical Systems Romania
13.10-14.15
Lunch break
From research to clinical applications
Chairmen Cristian Chiricuta and Stefano Boschi
14.15-15.00
Invited lecture - Peptide radiopharmaceuticals: The theranostic approach
Prof. Clemens Decristoforo, Department of Nuclear Medicine, Medical University,
Innsbruck
15.00-15.30
Evaluation of 177Lu - DOTA - NT and 177Lu – DOTA - SR48692 therapeutic
efficacy in murine experimental model
Dr. Iuliana Gruia, Institute of Oncology Prof Dr Al Trestioreanu, Bucharest
15.30-16.00
Radiolabelled peptide in diagnosis and therapy of neuroendocrine tumors
Dr. Mirela Gherghe, Institute of Oncology Prof Dr Al Trestioreanu, Bucharest
16.00-16.30
Clinical applications of molecular neuroimaging SPECT/CT and PET/CT
Dr. Adriana Rimbu, Nuclear Medicine Department, Clinical Hospital Colentina,
Bucharest
16.30-17.10
Nuclear medicine, beyond images
Dr. Doina Piciu, Dept. Nuclear Medicine and Endocrine Tumors “Ion Chiricuta”
Institute of Oncology Cluj-Napoca
17.10-17.30
Visits at Radiopharmaceutical Research Centre and Radioisotopes Production
Centre
18.30
Dinner at Crama Domneasca
Friday 05th April 2013
A promising generator produced PET radioisotope: Gallium-68
Chairmen Dana Niculae and Rodica Anghel
09.15-10.00
Invited lecture – 68Ga in radiopharmacy
Prof. Stefano Boschi, PET radiopharmacy, Department of Nuclear Medicine,
University Hospital, Bologna, Italy
10.00-10.45
Invited lecture - 68Ga radiopharmaceuticals: recent advances
Prof. Clemens Decristoforo, Department of Nuclear Medicie, Medical University,
Innsbruck, Austria
10.45-11.05
Preclinical evaluation of 68Ga-cycloRGD dimers for imaging and therapy follow-up
Ioana Esanu, Department of Radioisotopes and Radiation Metrology, IFIN-HH
11.05-11.25
Automation of Ga-68 radiosynthesis
Filip Puicea, Department of Radioisotopes and Radiation Metrology, IFIN-HH
11.25-11.45
Cofee break
Alternative methods for production of Mo-99 and Tc-99m
Chairmen John Mercer and Lidia Matei
11.45-12.30
Invited lecture - Recent Developments on 99mTc Production by Cyclotron
Lidia Matei, Best Theratronics, Radiochemistry Division, Ottawa Canada;
12.30-12.50
Production of 99Mo using LEU targets at INR Pitesti
Ana Maria Ivan, Institute for Nuclear Research Pitesti, Mioveni-Arges, Romania
12.50-13.10
Manipulation of isotope decay rates using the intensity of applied X- ray lasers
Nicolae Enaki, Institute of Applied Physics, Academy of Sciences of Moldova,
Moldova
13.10-13.30
A feasibility study on direct Cyclotron production of Tc-99m at IFIN-HH
Liviu Craciun, Department of Applied Nuclear Physics, IFIN-HH
13.30-14.00
Closing remarks
Dana Niculae, Department of Radioisotopes and Radiation Metrology, IFIN-HH
Poster presentations:
P1
Methods for 99Mo/99mTc obtaining at IFIN-HH-DRMR
C. Cimpeanu, C. Barna
P2
Bioaffinity of 177Lu-DOTA-NT and 177Lu-DOTA-SR Bioconjugates to neurotensin receptors
Diana Chiper, Valeria Lungu, Catalina Barna, Cristian Postolache, Viorel Fugaru,
Simona Manea, George Bubueanu
P3
Obtaining of 177Lu-DOTA-NT and 177Lu-DOTA-SR Bioconjugates
Diana Chiper, Valeria Lungu, Catalina Barna, Tuta Catalin, Marina Iliescu
P4
Oncology in canidae and felidae. A study case (2007 – 2012) at the University of Veterinary
Medicine Bucharest
Emilia Balint1,N.Manolescu2,G.Predoi3,C.Mateescu4
P5
F-18 SODIUM FLUORIDE PRODUCTION WITH TWO COMMERCIAL
SYNTHESIS MODULES
Hakan DEMİRCİ, Salim ÖZTÜRK, Hakan BAĞCI, Sinem ŞENSOY, Deniz KIVRAKDAL, Sait
KÖKOĞLU, Arda UYANIK, Turgay DOĞAN,
P6
[F-18]FLT PRODUCTION WITH TWO DIFFERENT PURIFICATION METHODS
Salim Öztürk, Hakan Demirci, Hakan Bağcı, Deniz Kıvrakdal, Sinem Şensoy
P7
IN HOUSE MAINTENANCE OF TWELVE CYCLOTRONS FROM DIFFERENT
MANUFACTURERS – THIRTEEN YEARS EXPERIENCE
Harun KÜÇÜKMİDİL, Volkan ÇAM, Merter UZUN, Akın AYDIN, Mustafa UZAL, Lütfiye GENCO